Articles

Editor's Page

• A Lost Opportunity for Chronic DME

  By Robert L. Avery, MD; and Allen C. Ho, MD

Feature Stories

• The Current Status of Stem Cells in Ophthalmology

  By Irv Arons

• Vail Vitrectomy: Controversial Elitism or Educational Masterpiece?

  By Kirk H. Packo, MD, FACS Chair, Vail Vitrectomy Scientific Program and Organizing Committee

Business of Retina
Pennsylvania Avenue Updates

• The Physician Payments Sunshine Act

  Will this legislation impede collaboration between physicians and industry?
  With William L. Rich III, MD

Clinical Trials for the Retina Specialist

• Recruiting for Invasive Clinical Trials

  By Aron Shapiro and Ashley Lafond

Fellows’ Focus

• Financial Advice for Young Physicians

  By Andre Witkin, MD; Alok S. Bansal, MD; and Nik London, MD

Retina Surgery
Retina Pearls

• Valved Cannula Systems

  This technology promotes safe and efficient vitrectomy surgery.

  By Daniel D. Esmaili, MD

Global Perspectives

• Combined Phacoemulsification and Pars Plana Vitrectomy

  Combining these procedures benefits both the surgeon and the patient.

  By Francesco Barca, MD; and Stanislao Rizzo, MD

Surgical Updates

• The Advent of Chandelier Illumination in Vitreoretinal Surgery

  A panel of surgeons has divergent views on when and how to use these devices.

  By Rohit Ross Lakhanpal, MD, FACS; and the Vit-Buckle Society

Oncology
Case Reports in Ocular Oncology

• Detection of a Second Primary Tumor During Whole-body Positron Emission Tomography for Choroidal Melanoma

  By Pradeep Venkatesh, MD; Prakash Agarwal, MD; Rakesh Kumar, MD; and Satpal Garg, MD

Cover Stories

• Ocular Drug Delivery Systems for the Posterior Segment: A Review

  By Noriyuki Kuno, PhD; and Shinobu Fujii

• Fluocinolone Implant Will Be Welcome Addition to Therapy Options for DME

  UK physician shares impressions from FAME Study.

  By Andrew J. Lotery, MD, FRCOphth

• Sustained Delivery for Retinal Vein Occlusion

  For many patients, this method of drug delivery is preferable to rapid attenuation.

  By Antonio Capone Jr., MD

• Drug Delivery Implants for Geographic Atrophy

  A number of sustained-delivery technologies are under study.

  By Baruch D. Kuppermann, MD, PhD

• Is Dry AMD Treatable?

  A new ophthalmic solution may halt disease progression.

  By George Chiou, PhD

• Are Topical Antibiotics Helpful as Prophylaxis ONLINE SURVEY for Intravitreal Injections?

  The community standard is evolving toward focusing on antisepsis.

  By Charles Wykoff, MD, PhD; and Harry W. Flynn Jr., MD

Medical Retina

• Double Endotamponade With Perfluorodecalin and Silicone Oil in Retinal Detachment Surgery

  A clinical study finds the technique effective in treatment of complicated retinal detachments.
  P.V. Lyskin, MD, PhD; and Elena G. Kazimirova, MD

New Instrumentation

• A New Scleral Depressor

  This new instrument is designed to allow for more effective examination of the fundus while being more comfortable and ergonomic for both the physician and patient.

  By Robert G. Josephberg, MD; and Eduardo Besser, MD

Departments

• 5Q With Hugo Quiroz-Mercado, MD

  Dr. Quiroz-Mercado is the Director of Ophthalmology at the Denver Health Medical Center and a Professor of Ophthalmology at the Rocky Mountain Lions Eye Institute, University of Colorado.

View All News >